Exclusion Criteria:~* Absence of a reliable caregiver who is willing to participate and comply with protocol
responsibilities~* Diabetes mellitus requiring medical therapy (diet-controlled diabetes is acceptable)~* Acute
or chronic liver failure, hepatitis within the last two years, or history of drug-induced liver transaminase
elevations~* Heart failure meeting New York Heart Association Grade III or IV criteria (i.e., functionally
disabling)~* Evidence of active gastrointestinal, renal, pulmonary, endocrine or cardiovascular system disease
sufficient to cause cognitive impairment or interfere with past levels of daily function; participants with
controlled hypertension (supine diastolic BP < 95mmHg), right bundle branch block (complete or partial) and
pacemakers may be included in the study; participants with thyroid disease also may be included in the study,
provided they are euthyroid on treatment~* Active treatment for cancer or history of cancer within 3 years of
screening (basal cell and squamous cells skin cancers are acceptable; incidental finding of carcinoma cells at
transurethral prostate resection without subsequent medical or surgical therapy is acceptable)~* Evidence of
other psychiatric/neurologic disorders sufficient to be the primary source of cognitive impairment (i.e.,
stroke, idiopathic Parkinson's disease, schizophrenia, bipolar or unipolar depression, seizure disorder, head
injury with loss of consciousness within the past year) or a modified Hachinski's ischemia score of 5 or
greater; delusions, hallucinations or depression not successfully treated or not on stable medical therapy for
these conditions 30 days prior to enrollment; known or suspected history (within the past 10 years) of
alcoholism or drug misuse~* Participants and/or caregivers who are unwilling or unable to fulfill the
requirements of the study~* Any condition which would make the participant or the caregiver, in the opinion of
the investigator, unsuitable for the study
